TY - JOUR T1 -肺动脉高压患者剥夺和预后:缺少剥夺对一种罕见疾病的影响?JF -欧洲呼吸杂志》乔和J - 10.1183/13993003.02334 -2019欧元SP - 1902334 AU Sofianopoulou Eleni盟——教堂,科林AU - Coghlan,格里非盟-霍华德,卢克AU -约翰逊,马丁AU -基利,大卫·g . AU -洛瑞·艾伦AU - Lordan,詹姆斯AU -威尔金斯,马丁·r . AU -麦芽汁,Stephen J . AU -莫雷尔,尼古拉斯·w . AU - ToshnerMark R. Y1 - 2020/01/01 UR - //www.qdcxjkg.com/content/early/2020/03/26/13993003.02334-2019.abstract N2 -在本杂志中，Pellino等人提出了生存分析，以评估剥夺如何影响肺动脉高压(PAH)[1]患者的预后。他们的结论是，在苏格兰，社会剥夺不是特发性(I)PAH或遗传性(H)PAH的重要转诊障碍或预后因素。考虑到描述因社会剥夺而分层的结果的文献的更广泛的背景，这可能显得令人惊讶。作者详尽地利用诊断时的地址和审查时的地址来分配剥夺评分，并将两者进行比较，发现两种方法无显著差异。他们还比较了分配给PAH病例的剥夺与基于苏格兰公民作为一个整体的预期剥夺，发现PAH患者比预期的社会剥夺更严重。最后，他们使用相同的生存单因素分析调整了年龄和性别，以评估几个临床变量如何与预后相关。脚注本手稿最近已被接受发表在欧洲呼吸杂志。在我们的制作团队进行编辑和排版之前，它以接受的形式在这里发表。在这些生产过程完成后，作者已经批准了结果的证明，文章将移动到最新一期的ERJ在线。 Please open or download the PDF to view this article.Conflict of interest: Dr. Sofianopoulou has nothing to disclose.Conflict of interest: Dr. Church has nothing to disclose.Conflict of interest: Dr. Coghlan reports grants and personal fees from Johnson & Johnson, personal fees from Glaxo Smith Klein, personal fees from Bayer, personal fees from MSD, outside the submitted work.Conflict of interest: Dr. Howard has nothing to disclose.Conflict of interest: Dr. Johnson reports grants and personal fees from Actelion, grants and personal fees from MSD, outside the submitted work.Conflict of interest: Dr. Kiely has nothing to disclose.Conflict of interest: Dr. Lawrie reports grants from British Heart Foundataion, grants from Medical Research Council, grants, personal fees and other from Actelion Pharmaceuticals Ltd, grants and personal fees from GlaxoSmithKline, outside the submitted work.Conflict of interest: Dr. Lordan has nothing to disclose.Conflict of interest: Dr. Wilkins has nothing to disclose.Conflict of interest: Dr. Wort has nothing to disclose.Conflict of interest: Dr. Morrell has nothing to disclose.Conflict of interest: Dr. Toshner reports personal fees from GSK, grants and personal fees from J&J/Actelion, grants from Merck, grants from Bayer, outside the submitted work. ER -